⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Official Title:

Study ID: NCT00044291

Study Description

Brief Summary: The purpose of this study is to determine whether the first line combination hormonal therapy of an experimental drug, atamestane, plus an FDA-approved drug, toremifene (Fareston®), is more effective than another approved drug, letrozole (Femara®), in delaying the growth of breast cancer in postmenopausal patients with locally advanced or metastatic breast cancer, and whether the side effects of the combination are different from the side effects of letrozole.

Detailed Description: Breast cancer cells are often very dependent on estrogens to continue to grow. Atamestane blocks the formation of estrogens and androgenic precursors in the body. Toremifene blocks circulating and intracellular estrogens from stimulating estrogen receptors in breast cancer cells. The goal of therapy with atamestane, an aromatase inhibitor, in combination with the estrogen receptor antagonist, toremifene, is to achieve maximal suppression of estrogen stimulation of breast cancer cells. This study is designed to determine whether combination therapy will lengthen the time to disease progression and the rate of objective response compared to single agent aromatase inhibitor therapy with letrozole.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Midwest Internal Medicine, PLLC, Lake Havasu City, Arizona, United States

Arizona Clinical Research Center, Tucson, Arizona, United States

California Cancer Care, Inc., Greenbrae, California, United States

Sharp Memorial Hospital, San Diego, California, United States

Innovative Medical Research of South Florida Inc., Miami Shores, Florida, United States

Georgia Cancer Specialists, Tucker, Georgia, United States

Maryland Hematology/Oncology Associates, Baltimore, Maryland, United States

Oncology Care Associates, PLLC, St. Joseph, Michigan, United States

Kansas City Oncology and Hematology Group, Kansas City, Missouri, United States

Great Falls Clinic-Oncology West, Great Falls, Montana, United States

Slocum-Dickson Medical Group, New Hartford, New York, United States

Hematology Oncology Consultants, Inc., Columbus, Ohio, United States

Oncology Consultants, Houston, Texas, United States

First Dynamic Healthcare Services, Inc., Killeen, Texas, United States

Cache Valley Cancer Treatment & Research Clinic, Logan, Utah, United States

Virginia Oncology Associates, Norfolk, Virginia, United States

Western Washington Oncology Inc., P.S., Olympia, Washington, United States

Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Ontario, Canada

Princess Margaret Hospital, Toronto, Ontario, Canada

McGill University, Department of Oncology, Montreal, Quebec, Canada

Arkhangelsk Regional Oncology Center, Department of Chemotherapy, Arkhangelsk, , Russian Federation

Tatarstan Republican Clinical Oncology Center, Kazan, , Russian Federation

Krasnodar Regional Clinical Oncology Center, Chemotherapy Department, Krasnodar, , Russian Federation

Leningrad Regional Oncology Center, Leningrad, , Russian Federation

Lipetsk Regional Oncology Center, Department of General Oncology, Lipetsk, , Russian Federation

Blokhin Cancer Research Center, Department of Chemotherapy and Combined Treatment of Tumors, Moscow, , Russian Federation

Blokhin Cancer Research Center, Department of Chemotherapy, Moscow, , Russian Federation

Blokhin Cancer Research Center, Department of Clinical Pharmacology and Chemotherapy, Moscow, , Russian Federation

Blokhin Cancer Research Center, Department of New Antitumor Drug Research, Moscow, , Russian Federation

Hertzen Research Institute of Oncology, Department of Chemotherapy, Moscow, , Russian Federation

Central Clinical Hospital of the Ministry of Transport n.a. Semashko, Department of Chemotherapy, Moscow, , Russian Federation

Moscow City Hospital #40, Department of Chemotherapy, Moscow, , Russian Federation

Moscow City Oncology Hospital #62, Moscow, , Russian Federation

Murmansk Regional Oncology Center, Murmansk, , Russian Federation

Municipal Clinical Hospital #1, Department of Breast Tumors, Oncology Department, Novosibirsk, , Russian Federation

Medical Radiological Research Center, Obninsk, , Russian Federation

Ryazan Regional Clinical Oncology Center, Ryazan, , Russian Federation

Samara Regional Oncology Center, Department of Chemotherapy, Samara, , Russian Federation

St. Petersburg City Oncology Center, St. Petersburg, , Russian Federation

Laboratory of Thoracic Oncology, St. Petersburg Pavlov State Medical University, Research Institute of Pulmonology, St. Petersburg, , Russian Federation

Petrov Research Institute of Oncology, Department of Biotherapy and Bone Marrow Transplantation, St. Petersburg, , Russian Federation

Petrov Research Institute of Oncology, Department of Breast Cancer, St. Petersburg, , Russian Federation

Petrov Research Institute of Oncology, Department of Chemotherapy, St. Petersburg, , Russian Federation

Stavropol Regional Oncology Center, Department of Chemotherapy, Stavropol, , Russian Federation

Research Institute of Oncology, Tomsk Scientific Center, Siberian Department of the Russian Academy of Medical Sciences, Department of Chemotherapy, Tomsk, , Russian Federation

V. Novgorod Regional Oncology Center, Department of Chemotherapy, V. Novgorod, , Russian Federation

Burdenko Voronezh Medical Academy, Oncology Department, Clinical Facility: Regional Clinical Oncology Center, Voronezh, , Russian Federation

Cherkassy Regional Oncology Center, Chemotherapy Department, Cherkassy, , Ukraine

Dnepropetrovsk State Medical Academy, Oncology Department. Clinical Facility: Dnepropetrovsk City Clinical Hospital #4, Dnepropetrovsk, , Ukraine

Donetsk State Medical University. Clinical Facility: Donetsk Regional Antineoplastic Center, Mammology Department, Donetsk, , Ukraine

Ivano-Frankovsk State Medical Academy; Oncology Department Clinical Facility: Ivano-Frankovsk Regional Oncology Center, Ivano-Frankovsk, , Ukraine

Kharkov State Medical University. Clinical Facility: Grigoriev Medical Radiology Institute, Chemotherapy Department, Kharkov, , Ukraine

Kharkov Medical Academy of Postgraduate Education, Oncology and Pediatric Oncology Department. Clinical Facility: Kharkov Regional Clinical Oncology Dispensary, Chemotherapy Department, Kharkov, , Ukraine

Kiev Central Clinical Hospital, Ukraine Security Services, Surgery Department, Kiev, , Ukraine

Kiev Oncology Institute, Ukraine Medical Science Academy, Department of Breast Tumors, Kiev, , Ukraine

Kiev Postgraduate Studies Medical Academy. Clinical Facility: Kiev City Oncology Hospital, Chemotherapy Department, Kiev, , Ukraine

National Medical University, Oncology Department. Clinical Facility: Kiev City Oncology Hospital, Surgery Department, Kiev, , Ukraine

Krivoy Rog City Oncology Center, Krivoy Rog, , Ukraine

Lviv State Medical University, Oncology and Medical Radiology Department. Clinical Facility: Lviv State Oncology Regional Clinical Diagnostic Center, Chemotherapy Department, Lviv, , Ukraine

Odessa State Medical University, Oncology Department. Clinical Facility: Odessa Regional Oncology Center, Chemotherapy Department, Odessa, , Ukraine

Uzhgorod National University Oncology Course of Surgery Department of Postgraduate Education Faculty Clinical Facility: Zakarpatye Regional Oncology Center, Uzhgorod, , Ukraine

Zaporozhye Statue Institute of Postgraduate Training. Oncology Department; Clinical Facility: Zaporozhye Regional Oncology Center, Zaporozhye, , Ukraine

Contact Details

Name: Paul Goss, M.D.

Affiliation: Princess Margaret Hospital, Canada

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: